More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1078 participants.
Also called NCT01510652
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 1,078 participants
- Sponsor
- Registry
-
NCT01510652
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Belgium, Canada, Finland, France, Germany, India, Israel, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01510652. Randomized; no masking; primary purpose prevention. Start 2011-11 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2015-10-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- More Options Available With a Quadripolar LV Lead pRovidE In-clinic Solutions to CRT Challenges
- Acronym
- MORE-CRT
- Condition
- Postoperative Cardiac Complication
- Condition
- Heart Failure
- Condition
- Left Ventricular Cardiac Dysfunction
- Condition
- Inappropriate Phrenic Nerve Stimulation
- Condition
- Perioperative/Postoperative Complications
- Intervention (Procedure)
- BiP Group
- Intervention (Device)
- Quad Group
- Lead sponsor
- Abbott Medical Devices
Record details
- Record id
cardio:ct-nct01510652- Content hash
9cc400aaee0412d93c15a4fa414ab309f3ce6ff6aaad00365e6671a5e87ddbc4